President Trump will announce concessions from Eli Lilly and Novo Nordisk that would lower the price of some of the companies ...

A heated bidding war has erupted between Novo Nordisk and Pfizer over U.S. biotech firm Metsera and its obesity drug assets, valued at $10 billion. Novo's higher offer has stirred tensions, with ...

A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 ...

The Trump administration is reportedly expected to announce a deal with Eli Lilly and Novo Nordisk on Thursday that would ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

Judge delivers major setback to pharma giant’s efforts to scupper rival’s surprise bid, in an increasingly bitter feud over ...

The court’s decision allows Metsera to walk away from its previous acquisition agreement with Pfizer in favor of Novo Nordisk ...

() -Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in return ...

Pressure from the FTC and Pfizer is building around Novo Nordisk’s bid to snatch obesity biotech Metsera: The antitrust ...

The FT reports Pfizer ( PFE +1.28%) has matched Novo Nordisk 's ( NVO +0.48%) bid for Metsera ( MTSR 2.46%) for up to $10 ...

Stock futures were little changed Thursday, a day after major indexes rebounded from a selloff in tech stocks caused by ...

CFO Sarah Friar said at the Wall Street Journal's Tech Live event on Wednesday that the ChatGPT creator was "looking for an ecosystem of banks, private equity, maybe even governmental" partners, as ...